BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kuddus R, Patzer J, Lopez R, Mazariegos G, Meighen B, Kramer D, Rao A. CLINICAL AND LABORATORY EVALUATION OF THE SAFETY OF A BIOARTIFICIAL LIVER ASSIST DEVICE FOR POTENTIAL TRANSMISSION OF PORCINE ENDOGENOUS RETROVIRUS: . Transplantation 2002;73:420-9. [DOI: 10.1097/00007890-200202150-00017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Kulig KM, Vacanti JP. Hepatic tissue engineering. Transpl Immunol. 2004;12:303-310. [PMID: 15157923 DOI: 10.1016/j.trim.2003.12.005] [Cited by in Crossref: 114] [Cited by in F6Publishing: 83] [Article Influence: 7.1] [Reference Citation Analysis]
2 Kuddus RH, Metes DM, Nalesnik MA, Logar AJ, Rao AS, Fung JJ. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells. Transpl Immunol 2004;13:15-24. [PMID: 15203124 DOI: 10.1016/j.trim.2004.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
3 Court FG, Wemyss-Holden SA, Dennison AR, Maddern GJ. Bioartificial liver support devices: historical perspectives. ANZ J Surg. 2003;73:739-748. [PMID: 12956791 DOI: 10.1046/j.1445-2197.2003.02741.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
4 Chen Z, Ding YT. Functional evaluation of a new bioartificial liver system in vitro and in vitro. World J Gastroenterol. 2006;12:1312-1316. [PMID: 16534893 DOI: 10.3748/wjg.v12.i8.1857] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
5 Vacanti JP, Kulig KM. Liver cell therapy and tissue engineering for transplantation. Seminars in Pediatric Surgery 2014;23:150-5. [DOI: 10.1053/j.sempedsurg.2014.05.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
6 Korsgren O, Buhler LH, Groth C. Toward clinical trials of islet xenotransplantation: Commentary. Xenotransplantation 2003;10:289-92. [DOI: 10.1034/j.1399-3089.2003.00077.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
7 Kobayashi C, Matsunami K, Omori T, Nakatsu S, Nakahata K, Xu H, Shirakura R, Fukuzawa M, Miyagawa S. Features of a newly cloned pig C1 esterase inhibitor. J Biochem 2006;140:421-7. [PMID: 16916842 DOI: 10.1093/jb/mvj175] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
8 . Porcine endogenous retrovirus - advances, issues and solutions: Commentaries. Xenotransplantation 2002;9:373-5. [DOI: 10.1034/j.1399-3089.2002.02056_3.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
9 Di Nicuolo G, D'Alessandro A, Andria B, Scuderi V, Scognamiglio M, Tammaro A, Mancini A, Cozzolino S, Di Florio E, Bracco A, Calise F, Chamuleau RA. Long-term absence of porcine endogenous retrovirus infection in chronically immunosuppressed patients after treatment with the porcine cell-based Academic Medical Center bioartificial liver. Xenotransplantation. 2010;17:431-439. [PMID: 21158944 DOI: 10.1111/j.1399-3089.2010.00617.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
10 Chiang C, Pan Y, Chou L, Fang C, Wang S, Yang C, Chang H. Functional epitopes on porcine endogenous retrovirus envelope protein interacting with neutralizing antibody combining sites. Virology 2007;361:364-71. [DOI: 10.1016/j.virol.2006.11.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Han B, Shi XL, Zhang Y, Chu XH, Gu JY, Xiao JQ, Ren HZ, Tan JJ, Gu ZZ, Ding YT. Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study. Eur J Med Res. 2012;17:13. [PMID: 22632261 DOI: 10.1186/2047-783x-17-13] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Han B, Shi XL, Zhang Y, Gu ZZ, Yuan XW, Ren HZ, Qiu Y, Ding YT. No transmission of porcine endogenous retrovirus in an acute liver failure model treated by a novel hybrid bioartificial liver containing porcine hepatocytes. Hepatobiliary Pancreat Dis Int. 2015;14:492-501. [PMID: 26459725 DOI: 10.1016/s1499-3872(15)60401-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Wang HH, Wang YJ, Liu HL, Liu J, Huang YP, Guo HT, Wang YM. Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system. World J Gastroenterol 2006;12:1287-91. [PMID: 16534887 DOI: 10.3748/wjg.v12.i8.1287] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
14 Qian Y, Lanjuan L, Jianrong H, Jun L, Hongcui C, Suzhen F, Xia Y, Shuhong Y. Study of Severe Hepatitis Treated with a Hybrid Artificial Liver Support System. Int J Artif Organs 2003;26:507-13. [DOI: 10.1177/039139880302600609] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
15 Hochleitner B, Hengster P, Duo L, Bucher H, Klima G, Margreiter R. A novel bioartificial liver with culture of porcine hepatocyte aggregates under simulated microgravity. Artif Organs 2005;29:58-66. [PMID: 15644085 DOI: 10.1111/j.1525-1594.2004.29014.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
16 Denner J, Schuurman H, Patience C. Chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses. Xenotransplantation 2009;16:239-48. [DOI: 10.1111/j.1399-3089.2009.00544.x] [Cited by in Crossref: 61] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
17 Catapano G, Patzer JF 2nd, Gerlach JC. Transport advances in disposable bioreactors for liver tissue engineering. Adv Biochem Eng Biotechnol 2009;115:117-43. [PMID: 19499208 DOI: 10.1007/10_2008_34] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
18 Yagi H, Parekkadan B, Suganuma K, Soto-Gutierrez A, Tompkins RG, Tilles AW, Yarmush ML. Long-term superior performance of a stem cell/hepatocyte device for the treatment of acute liver failure. Tissue Eng Part A 2009;15:3377-88. [PMID: 19397469 DOI: 10.1089/ten.TEA.2008.0681] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
19 Pakhomov O, Martignat L, Honiger J, Clémenceau B, Säi P, Darquy S. AN69 Hollow Fiber Membrane will Reduce but Not Abolish the Risk of Transmission of Porcine Endogenous Retroviruses. Cell Transplant 2005;14:749-56. [DOI: 10.3727/000000005783982468] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 Valdes-Gonzalez R, Dorantes LM, Bracho-Blanchet E, Rodríguez-Ventura A, White DJ. No evidence of porcine endogenous retrovirus in patients with type 1 diabetes after long-term porcine islet xenotransplantation. J Med Virol. 2010;82:331-334. [PMID: 20029803 DOI: 10.1002/jmv.21655] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
21 Binette TM, Seeberger KL, Lyon JG, Rajotte RV, Korbutt GS. Porcine Endogenous Retroviral Nucleic Acid in Peripheral Tissues Is Associated with Migration of Porcine Cells Post Islet Transplant. Am J Transplant 2004;4:1051-60. [DOI: 10.1111/j.1600-6143.2004.00460.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
22 Diekmann S, Bader A, Schmitmeier S. Present and Future Developments in Hepatic Tissue Engineering for Liver Support Systems : State of the art and future developments of hepatic cell culture techniques for the use in liver support systems. Cytotechnology 2006;50:163-79. [PMID: 19003077 DOI: 10.1007/s10616-006-6336-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
23 Nishitai R, Ikai I, Shiotani T, Katsura N, Matsushita T, Yamanokuchi S, Matsuo K, Sugimoto S, Yamaoka Y. Absence of PERV infection in baboons after transgenic porcine liver perfusion. J Surg Res. 2005;124:45-51. [PMID: 15734478 DOI: 10.1016/j.jss.2004.09.006] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
24 Kuddus RH, Gandhi CR, Rehman KK, Guo F, Watkins SC, Valdivia LA, Fung JJ. Some morphological, growth, and genomic properties of human cells chronically infected with porcine endogenous retrovirus (PERV). Genome 2003;46:858-69. [DOI: 10.1139/g03-064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
25 Liu Q, Liu Z, Dalakas E. Prevalence of porcine endogenous retrovirus in Chinese pig breeds and in patients treated with a porcine liver cell-based bioreactor. World J Gastroenterol 2005;11:4727-30. [PMID: 16094718 DOI: 10.3748/wjg.v11.i30.4727] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
26 Marcucci KT, Argaw T, Wilson CA, Salomon DR. Identification of two distinct structural regions in a human porcine endogenous retrovirus receptor, HuPAR2, contributing to function for viral entry. Retrovirology 2009;6:3. [PMID: 19144196 DOI: 10.1186/1742-4690-6-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
27 Chamuleau RA, Poyck PP, van de Kerkhove MP. Bioartificial liver: its pros and cons. Ther Apher Dial. 2006;10:168-174. [PMID: 16684219 DOI: 10.1111/j.1744-9987.2006.00359.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 29] [Article Influence: 2.7] [Reference Citation Analysis]
28 Allen JW, Bhatia SN. Improving the next generation of bioartificial liver devices. Semin Cell Dev Biol. 2002;13:447-454. [PMID: 12468246 DOI: 10.1016/S1084952102001337] [Cited by in Crossref: 56] [Cited by in F6Publishing: 11] [Article Influence: 3.1] [Reference Citation Analysis]
29 Burra P, Samuel D, Wendon J, Pietrangelo A, Gupta S. Strategies for liver support: from stem cells to xenotransplantation. Journal of Hepatology 2004;41:1050-9. [DOI: 10.1016/j.jhep.2004.10.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
30 Schrem H, Kleine M, Borlak J, Klempnauer J. Physiological incompatibilities of porcine hepatocytes for clinical liver support. Liver Transpl 2006;12:1832-40. [PMID: 17133583 DOI: 10.1002/lt.20918] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
31 Han B, Shi XL, Xiao JQ, Zhang Y, Chu XH, Gu JY, Tan JJ, Gu ZZ, Ding YT. Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes. World J Gastroenterol 2011;17:2774-80. [PMID: 21734784 DOI: 10.3748/wjg.v17.i22.2774] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
32 Baquerizo A, Bañares R, Saliba F. Current Clinical Status of the Extracorporeal Liver Support Devices. Transplantation of the Liver. Elsevier; 2015. pp. 1463-87. [DOI: 10.1016/b978-1-4557-0268-8.00107-x] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Shah CA, Böni J, Bisset LR, Seebach JD, Schüpbach J. Ultra-sensitive and specific detection of porcine endogenous retrovirus (PERV) using a sequence-capture real-time PCR approach. Journal of Virological Methods 2003;109:209-16. [DOI: 10.1016/s0166-0934(03)00073-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Frühauf J, Mertsching H, Giri S, Frühauf NR, Bader A. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver International 2009;29:1553-61. [DOI: 10.1111/j.1478-3231.2009.02087.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
35 Denner J, Tönjes RR. Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses. Clin Microbiol Rev. 2012;25:318-343. [PMID: 22491774 DOI: 10.1128/cmr.05011-11] [Cited by in Crossref: 116] [Cited by in F6Publishing: 45] [Article Influence: 12.9] [Reference Citation Analysis]
36 Levy MF, Argaw T, Wilson CA, Brooks J, Sandstrom P, Merks H, Logan J, Klintmalm G. No evidence of PERV infection in healthcare workers exposed to transgenic porcine liver extracorporeal support. Xenotransplantation 2007;14:309-15. [DOI: 10.1111/j.1399-3089.2007.00408.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
37 Choi HJ, Kim J, Kim JY, Lee HJ, Wee WR, Kim MK, Hwang ES. Long-term safety from transmission of porcine endogenous retrovirus after pig-to-non-human primate corneal transplantation. Xenotransplantation 2017;24. [PMID: 28503733 DOI: 10.1111/xen.12314] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
38 De Deyne PG, Kladakis SM. Bioscaffolds in tissue engineering: a rationale for use in the reconstruction of musculoskeletal soft tissues. Clin Podiatr Med Surg 2005;22:521-32, v. [PMID: 16213377 DOI: 10.1016/j.cpm.2005.07.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
39 Di Nicuolo G, van de Kerkhove MP, Hoekstra R, Beld MG, Amoroso P, Battisti S, Starace M, di Florio E, Scuderi V, Scala S, Bracco A, Mancini A, Chamuleau RA, Calise F. No evidence of in vitro and in vivo porcine endogenous retrovirus infection after plasmapheresis through the AMC-bioartificial liver. Xenotransplantation 2005;12:286-92. [PMID: 15943777 DOI: 10.1111/j.1399-3089.2005.00226.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]